In Vivo preclinical

Method of Growth Factor Delivery for Accelerated Wound Healing

SUMMARY Appearance of ulcers and slow wound healing are a hallmark symptom of several autoimmune disorders including type II diabetes. Current treatment approaches rely on antiquated bandaging, however bulkiness and inconvenience often result in low patient compliance. Growth factor-based therapies have demonstrated promise in clinical trials, but the high dosing… Read More

Q11: a Highly Homogeneous Multivalent and Single-component Vaccine Adjuvating Platform

SUMMARY There is a limited choice in clinically approved adjuvants for vaccine development. Current solutions are themselves immunogenic, causing injection site swelling and reactions. The inventors developed a 15 amino acid peptide adjuvant (Q11) that forms a highly homogeneous network of laterally assembled beta sheet fivers in aqueous solution. When… Read More